Monthly News Roundup - October 2022

FDA Expands AbbVie’s Rinvoq Indications to Include Non-Radiographic Axial Spondyloarthritis 
This past month, the FDA approved Rinvoq (upadacitinib) for the treatment of adults with active non-radiographic axial spondyloarthritis...